C-Reactive Protein and Bone Pain at Diagnosis Predict the Outcome of Pediatric Langerhans Cell Histiocytosis with Single-System Multifocal Lesions: Result of The Japan Langerhans Cell Histiocytosis Study Group-02 Protocol Study

被引：0
|
作者：
Morimoto, Akira [1 ]
Shioda, Yoko [2 ]
Imamura, Toshihiko [3 ]
Kudo, Kazuko [4 ]
Kitoh, Toshiyuki [5 ]
Kawaguchi, Hiroshi [6 ]
Goto, Hiroaki [7 ]
Kosaka, Yoshiyuki [8 ]
Tsunematsu, Yukiko [9 ]
Imashuku, Shinsaku [10 ]
机构：
[1] Jichi Med Univ Med, Dept Pediat, Shimotsuke, Japan
[2] Natl Ctr Child Hlth & Dev, Pediat Canc Ctr, Tokyo, Japan
[3] Kyoto Prefectural Univ Med, Dept Pediat, Kyoto, Japan
[4] Fujita Hlth Univ, Sch Med, Dept Pediat, Toyoake, Aichi, Japan
[5] Aichi Gakuin Univ, Sch Pharm, Pediat Lab, Nagoya, Aichi, Japan
[6] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Pediat, Hiroshima, Japan
[7] Kanagawa Childrens Med Ctr, Div Hematol Oncol, Yokohama, Kanagawa, Japan
[8] Hyogo Prefectural Kobe Childrens Hosp, Childrens Canc Ctr, Dept Hematol & Oncol, Kobe, Hyogo, Japan
[9] Juntendo Univ, Sch Med, Dept Pediat & Adolescent Med, Tokyo, Japan
[10] Uji Tokushukai Med Ctr, Dept Lab Med, Uji, Kyoto, Japan
来源：
PEDIATRIC BLOOD & CANCER | 2017年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S26 / S27
页数：2
相关论文
共 20 条
  • [1] Intensification of induction therapy and prolongation of maintenance therapy did not improve the outcome of pediatric Langerhans cell histiocytosis with single-system multifocal bone lesions: results of the Japan Langerhans Cell Histiocytosis Study Group-02 Protocol Study
    Akira Morimoto
    Yoko Shioda
    Toshihiko Imamura
    Kazuko Kudo
    Toshiyuki Kitoh
    Hiroshi Kawaguchi
    Hiroaki Goto
    Yoshiyuki Kosaka
    Yukiko Tsunematsu
    Shinsaku Imashuku
    [J]. International Journal of Hematology, 2018, 108 : 192 - 198
  • [2] Intensification of induction therapy and prolongation of maintenance therapy did not improve the outcome of pediatric Langerhans cell histiocytosis with single-system multifocal bone lesions: results of the Japan Langerhans Cell Histiocytosis Study Group-02 Protocol Study
    Morimoto, Akira
    Shioda, Yoko
    Imamura, Toshihiko
    Kudo, Kazuko
    Kitoh, Toshiyuki
    Kawaguchi, Hiroshi
    Goto, Hiroaki
    Kosaka, Yoshiyuki
    Tsunematsu, Yukiko
    Imashuku, Shinsaku
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2018, 108 (02) : 192 - 198
  • [3] Improved outcome in the treatment of pediatric multifocal Langerhans cell histiocytosis - Results from the Japan Langerhans cell histiocytosis study group-96 protocol study
    Morimoto, Akira
    Ikushima, Satoshi
    Kinugawa, Naoko
    Ishii, Eiichi
    Kohdera, Urara
    Sako, Masahiro
    Fujimoto, Junichiro
    Bessho, Fumio
    Horibe, Keizo
    Tsunematsu, Yukiko
    Imashuku, Shinsaku
    [J]. CANCER, 2006, 107 (03) : 613 - 619
  • [4] INTENSIFIED AND PROLONGED THERAPY DID NOT IMPROVE THE OUTCOME IN LANGERHANS CELL HISTIOCYTOSIS WITH SINGLE-SYSTEM MULTIFOCAL BONE LESIONS; RESULTS OF JLSG-02 PROTOCOL STUDY
    Morimoto, Akira
    Shioda, Yoko
    Imamura, Toshihiko
    Kudo, Kazuko
    Ishii, Eiichi
    Horibe, Keizo
    Bessho, Fumio
    Tsunematsu, Yukiko
    Imashuku, Shinsaku
    [J]. PEDIATRIC BLOOD & CANCER, 2015, 62 : S133 - S134
  • [5] Intensified and prolonged therapy comprising cytarabine, vincristine and prednisolone improves outcome in patients with multisystem Langerhans cell histiocytosis: results of the Japan Langerhans Cell Histiocytosis Study Group-02 Protocol Study
    Akira Morimoto
    Yoko Shioda
    Toshihiko Imamura
    Kazuko Kudo
    Hiroshi Kawaguchi
    Kazuo Sakashita
    Masahiro Yasui
    Yuhki Koga
    Ryoji Kobayashi
    Eiichi Ishii
    Junichiro Fujimoto
    Keizo Horibe
    Fumio Bessho
    Yukiko Tsunematsu
    Shinsaku Imashuku
    [J]. International Journal of Hematology, 2016, 104 : 99 - 109
  • [6] Intensified and prolonged therapy comprising cytarabine, vincristine and prednisolone improves outcome in patients with multisystem Langerhans cell histiocytosis: results of the Japan Langerhans Cell Histiocytosis Study Group-02 Protocol Study
    Morimoto, Akira
    Shioda, Yoko
    Imamura, Toshihiko
    Kudo, Kazuko
    Kawaguchi, Hiroshi
    Sakashita, Kazuo
    Yasui, Masahiro
    Koga, Yuhki
    Kobayashi, Ryoji
    Ishii, Eiichi
    Fujimoto, Junichiro
    Horibe, Keizo
    Bessho, Fumio
    Tsunematsu, Yukiko
    Imashuku, Shinsaku
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2016, 104 (01) : 99 - 109
  • [7] Outcome of Children with Langerhans Cell Histiocytosis and Single-System Involvement: A Retrospective Study at a Single Center
    Gao, Yi-Jin
    Su, Meng
    Ci, Pan
    Jing, Chen
    Jing-Yan, Tang
    [J]. PEDIATRIC BLOOD & CANCER, 2017, 64 : S10 - S10
  • [8] Outcome of children with Langerhans cell histiocytosis and single-system involvement: A retrospective study at a single center in Shanghai, China
    Su, Meng
    Gao, Yi-Jin
    Pan, Ci
    Chen, Jing
    Tang, Jing-Yan
    [J]. PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2018, 35 (7-8) : 385 - 392
  • [9] Incidental Diagnosis on Orthopantomography of Langerhans Cell Histiocytosis with Multifocal Jaw Involvement: A Case Report of Single-System Disease
    Bugshan, Amr S.
    Alsaati, Mohammed A.
    Syed, Faiyaz A.
    Almulhim, Khalid S.
    Abdulhady, Adel, I
    [J]. AMERICAN JOURNAL OF CASE REPORTS, 2020, 21 : e928307 - 1
  • [10] Therapeutic outcome of multifocal Langerhans cell histiocytosis in adults treated with the Special C regimen formulated by the Japan LCH Study Group
    Morimoto, Akira
    Shimazaki, Chihiro
    Takahashi, Satoshi
    Yoshikawa, Kouhei
    Nishimura, Ryosei
    Wakita, Hisashi
    Kobayashi, Yutaka
    Kanegane, Hirokazu
    Tojo, Arinobu
    Imamura, Toshihiko
    Imashuku, Shinsaku
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2013, 97 (01) : 103 - 108
12